PART I. REGULATORY AND MANUFACTURING CONSIDERATIONS
Appendix I Dissolution Testing Requirements of Compressed Dosage Forms
Appendix II Approved Excipients in Compressed Solid Dosage Forms
PART II. MANUFACTURING FORMULATIONS
PART III. TABLET COATING FORMULATIONS
PART IV. COMPOSITION OF PROPRIETARY PRODUCTS APPROVED IN THE US
Sararfaraz K. Niazi:
He has been teaching and conducting research in the pharmaceutical industry for over 35 years. He has authored hundreds of scientific papers, textbooks, and presentations on the topics of pharmaceutical formulation, biopharmaceutics, and pharmacokinetics of drugs. He is also an inventor with scores of patents in the field of drug and dosage form delivery systems; he is also licensed to practice law before the U.S. Patent and Trademark Office. Having formulated hundreds of products from the most popular consumer entries to complex biotechnology-derived products, he has accumulated a wealth of knowledge in the science and art of formulating and regulatory filings of investigational new drugs (INDs) and new drug applications (NDAs). Dr. Niazi advises the pharmaceutical industry internationally on issues related to formulations, cGMP compliance, pharmacokinetics and bioequivalence evaluation, and intellectual property issues (http://www.pharmsci.com).

